The company's indigenously developed needle-free three-dose Covid-19 vaccine ZyCoVD was granted emergency use authorisation (EUA) by the drug regulator on Friday, making it the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country
from Top Business News- News18.com https://ift.tt/3mleWKN
via IFTTT
No comments:
Post a Comment